The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy-Reference-Cited by-同舟云学术

The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy

Published:2011-11 Issue:11 Volume:22 Page:2381-2386
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Geffen D.B.,Abu-Ghanem S.,Sion-Vardy N.,Braunstein R.,Tokar M.,Ariad S.,Delgado B.,Bayme M.,Koretz M.

Funder

Israel Cancer Association

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/11/2381/523845/mdq769.pdf

Reference25 articles.

1. Gene-expression signatures in breast cancer;Sotirou;N Engl J Med,2009

2. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients;Habel;Breast Cancer Res,2006

3. A multigene assay to predict recurrence of tamoxifen-treated, node negative breast cancer;Paik;N Engl J Med,2004

4. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer;Paik;J Clin Oncol,2006

5. Development of the 21-gene assay and its application in clinical practice and clinical trials;Sparano;J Clin Oncol,2008

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing;Cancers;2023-01-31

2. Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: An international guidelines-based approach;Human Pathology Reports;2021-11

3. Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America;JCO Global Oncology;2021-08

4. Substantial Reduction in Adjuvant Chemotherapy With the Use of the 21-Gene Test to Manage Early Breast Cancer in a Public Hospital in Brazil;JCO Global Oncology;2021-07

5. Association of 21-Gene Assay (OncotypeDX) Testing and Receipt of Chemotherapy in the Medicare Breast Cancer Patient Population Following Initial Adoption;Clinical Breast Cancer;2020-12